title: Renin-Angiotensin System Blocker Fetopathy.
authors.affiliation: Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Janet D
authors.initials: JD
authors.lastname: Cragan
authors.affiliation: Veterans Affairs Puget Sound, Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.
authors.forename: Bessie A
authors.initials: BA
authors.lastname: Young
authors.affiliation: Departments of Medicine and Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi. Electronic address: acorrea@umc.edu.
authors.forename: Adolfo
authors.initials: A
authors.lastname: Correa
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D008297:Male; D018811:Maternal Exposure; D009398:Nephrology / Q000379:methods*; D011247:Pregnancy; D012084:Renin-Angiotensin System
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors